Steven Oh

Dr. Steven Oh is Deputy Director of Office of Cellular Therapy and Human Tissue in CBER, FDA. He oversees product quality review and policy development programs focused on cell therapy products, tissue-engineered products, combination products, and related medical devices. In addition, he heads the bioinformatics regulatory group in CBER. Dr. Oh has been with CBER for over 17 years and served in the past as Director and Deputy Director of Division of Cellular and Gene Therapies, Chief of Cell Therapy Branch, and Combination Product Team Leader. His scientific and regulatory interests include emerging novel technologies in regenerative medicine therapies and individualized medicine, standards development and use, and global regulatory convergence in advanced therapy products. Before joining FDA, Dr. Oh served on the faculty of Tufts University School of Medicine. He was trained as a cell biologist and biochemist at the University of Michigan, Johns Hopkins University School of Medicine, and Massachusetts Institute of Technology.